Your Article Summary
Taro and Quinnova Announce Agreement to Co-Promote Neosalus and Cleanse and Treat in the United States
Taro Pharmaceuticals USA, 06/11/09
Taro Pharmaceutical Industries Ltd. and Quinnova Pharmaceuticals, Inc. announced that Taro's U.S. subsidiary and Quinnova have entered into an agreement to co-promote "Neosalus" and "Cleanse and Treat" in the United States.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Sanofi-aventis to acquire Oenobiol, French leader in nutritional beauty supplements
Sanofi-aventis, 11/02/09
Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09
New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09
Article Search
Sponsor


See Latest Articles


